Evidence map›Paper›PMID 20832333›Full record

ReviewSeminars in immunology2010

Epigenetic control of recombination in the immune system.

Yehudit Bergman, Howard Cedar

Abstract readReview
In one paragraph

Review in Seminars in immunology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Review
  2. Article
  3. Regulated large-scale nucleosome density patterns and precise nucleosome positioning correlate with V(D)J recombination.Proceedings of the National Academy of Sciences of the United States of America · 2016
    Article
  4. Review
  5. To κ(+) B or not to κ(+) B.Nature immunology · 2015
    Article
  6. Article
  7. Epigenetic mechanisms and models in the origins of asthma.Current opinion in allergy and clinical immunology · 2013
    Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Epigenetics of haematopoietic cell development.Nature reviews. Immunology · 2011
    Review
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Yehudit BergmanDepartment of Developmental Biology and Cancer Research, The Hebrew University, Hadassah Medical School, Jerusalem 91120, Israel. yehudit.bergman@huji.ac.il
Howard Cedar

Funding

MOLECULAR MECHANISMS UNDERLYING LGK ALLELIC EXCLUSIONR01GM060951 · NIGMS · HEBREW UNIVERSITY OF JERUSALEM · PI BERGMAN, YEHUDIT · 2000 to 2009
$968k
NIGMS NIH HHS R01 GM060951
6 · The paper itself

Abstract

Immune receptor gene expression is regulated by a series of developmental events that modify their accessibility in a locus, cell type, stage and allele-specific manner. This is carried out by a programmed combination of many different molecular mechanisms, including region-wide replication timing, changes in nuclear localization, chromatin contraction, histone modification, nucleosome positioning and DNA methylation. These modalities ultimately work by controlling steric interactions between receptor loci and the recombination machinery.

Indexed as

EpigenomicsRecombination, GeneticAnimalsHumansImmune SystemReceptors, AntigenVDJ ExonsReceptors, Antigen

Identifiers

PMID20832333
PMCPMC2981633

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.